Tolerability and Clinical Outcomes With Anesthesia Dose Reduction During Electroconvulsive Therapy.

ABSTRACT:

Importance

Electroconvulsive therapy (ECT) practice during the COVID-19 pandemic necessitated restriction of bag-valve mask (BVM) ventilation to minimize disease transmission through aerosolization. To reduce BVM use, many sites decreased doses of anesthesia agents, but the associations of such dose reduction with clinical and tolerability outcomes are unknown.

Objectives

To investigate the association of COVID-19 pandemic modifications in ECT, including reduction in anesthetic dosage and BVM use, with the rates of clinical complications and clinical outcomes.

Design, setting, and participants

This retrospective cohort study included data from patients receiving an index course of ECT for any clinical indication treated with methohexital and succinylcholine between Ma

SUBMITTER: Espinola CW 

PROVIDER: S-EPMC11868969 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature